Renal-cell carcinoma: tumour markers, T-cell epitopes, and potential for new therapies

Overview of attention for article published in Lancet Oncology, April 2003

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

patent: 9 patents

Readers on

mendeley: 18 Mendeley

So far, Altmetric has seen 9 patents that reference this research output.

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal…

Grant US-11938176-B2

United States of America

26 Mar 2024

Method of treating renal cancer using carbonic anhydrase IX (G250) antibodies

Grant US-11174323-B2

United States of America

16 Nov 2021

Carbonic anhydrase IX (G250) antibodies and methods of use thereof

Grant US-10450383-B2

United States of America

22 Oct 2019

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST…

Application EP-3517126-A1

European Patent Office

31 Jul 2019

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 5 additional patents.